Table 4.
Scientific name | MIC/MBCMFC | Concentration of extracts in μg/ml on pathogen bacteria and fungi | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gram positive bacteria | Gram negative bacteria | Fungi | |||||||||
S. aureus | E. faecalis | E.coli | K. pneumoniae | C. albicans | |||||||
ATCC | MRSA | ATCC | MDR | ATCC | MDR | ATCC | MDR | ATCC | Sample | ||
C.englerianum | MIC | 16.0 | 16.0 | 1.0 | 1.0 | 64.0 | 64.0 | 2.0 | 2.0 | 128.0 | 64.0 |
MBC/MFC | 32.0 | 32.0 | 2.0 | 2.0 | 128.0 | 128.0 | 2.0 | 2.0 | 128.0 | 128.0 | |
E. depauperata | MIC | 4.0 | 4.0 | 4.0 | 4.0 | 128.0 | 128.0 | 16.0 | 16.0 | NT | 64.0 |
MBC/MFC | 4.0 | 8.0 | 8.0 | 8.0 | 128.0 | 128.0 | 16.0 | 16.0 | NT | 128.0 | |
L. adoensis | MIC | 64.0 | 32.0 | 16.0 | 16.0 | 64.0 | 64.0 | 16.0 | 16.0 | 384.0 | 512.0 |
MBC/MFC | 128.0 | 128.0 | 16.0 | 16.0 | 64.0 | 64.0 | 32.0 | 32.0 | NT | NT | |
D. penninervium | MIC | 8.0 | 8.0 | 8.0 | 16.0 | 16.0 | 16.0 | 16.0 | 16.0 | 128.0 | 128.0 |
MBC/MFC | 16.0 | 16.0 | 8.0 | 8.0 | 16.0 | 16.0 | 32.0 | 32.0 | 128.0 | 128.0 | |
R. abyssinicus | MIC | 16.0 | 16.0 | 64.0 | 64.0 | 128.0 | 128.0 | 16.0 | 16.0 | 32.0 | 16.0 |
MBC/MFC | 32.0 | 16.0 | 128.0 | 128.0 | 64.0 | 64.0 | 32.0 | 16.0 | 64.0 | 32.0 | |
C. pustulatus | MIC | 64.0 | 64.0 | 4.0 | 4.0 | 32.0 | 32.0 | 8.0 | 8.0 | 128.0 | 256.0 |
MBC/MFC | 64.0 | 64.0 | 8.0 | 8.0 | 64.0 | 64.0 | 16.0 | 16.0 | 128.0 | NT | |
Modern drug | 0.1Ce | ++ | 0.1C | ++ | 0.1C | ++ | 0.1C | ++ | 0.3F | 0.3F |
C = 5 μg ciprofloxacin, Ce Cefoxitin, F = 20 μg ketoconazole, ++ = Growth has been seen, NT Not tested MDR = < 16 mm, ATCC > 21 mm IZ